France· FR:69091949
QDENGA, poudre et solvant pour solution injectable en seringue préremplie
A medicinal product containing sérotype 4 du virus de la dengue, vivant, attenué + sérotype 2 du virus de la dengue, vivant, attenué + sérotype 1 du virus de la dengue, vivant, attenué + sérotype 3 du virus de la dengue, vivant, attenué, registered in France by TAKEDA PHARMACEUTICALS INTERNATIONAL (IRLANDE).
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- SÉROTYPE 4 DU VIRUS DE LA DENGUE, VIVANT, ATTENUÉ + SÉROTYPE 2 DU VIRUS DE LA DENGUE, VIVANT, ATTENUÉ + SÉROTYPE 1 DU VIRUS DE LA DENGUE, VIVANT, ATTENUÉ + SÉROTYPE 3 DU VIRUS DE LA DENGUE, VIVANT, ATTENUÉ
- Manufacturer
- TAKEDA PHARMACEUTICALS INTERNATIONAL (IRLANDE)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip1334009302664581 flacon en verre de 1 dose - 1 seringue préremplie en verre de 0,5 mL + 2 aiguilles
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d27ae701-5547-4fb7-a9b2-51f06693e469 GET /v1/drugs/d27ae701-5547-4fb7-a9b2-51f06693e469?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "69091949",
"date_amm": "2022-12-05",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/22/1699",
"substance": "SÉROTYPE 4 DU VIRUS DE LA DENGUE, VIVANT, ATTENUÉ + SÉROTYPE 2 DU VIRUS DE LA DENGUE, VIVANT, ATTENUÉ + SÉROTYPE 1 DU VIRUS DE LA DENGUE, VIVANT, ATTENUÉ + SÉROTYPE 3 DU VIRUS DE LA DENGUE, VIVANT, ATTENUÉ",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "poudre et solvant pour solution injectable",
"voies_administration": "sous-cutanée",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Oui"
}See everything about sérotype 4 du virus de la dengue, vivant, attenué + sérotype 2 du virus de la dengue, vivant, attenué + sérotype 1 du virus de la dengue, vivant, attenué + sérotype 3 du virus de la dengue, vivant, attenué.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.